Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

B cells are associated with survival and immunotherapy response in sarcoma

(2020) Florent Petitprez et al.   NATURE

Landmark analysis: A primer

(2019) Charity J. Morgan   JOURNAL OF NUCLEAR CARDIOLOGY

Screening of disorders associated with osteosarcoma by integrated network analysis

(2019) Yongfeng Dou et al.   BIOSCIENCE REPORTS

A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma

(2019) Feng Liu et al.   Genes

Identification of prognostic genes in the acute myeloid leukemia microenvironment

(2019) Shaoxin Huang et al.   Aging-US

Systematic screening identifies a 2‐gene signature as a high‐potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma

(2019) Qinsheng Hu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma

(2019) Jian-Guo Zhou et al.   GYNECOLOGIC ONCOLOGY

Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer

(2018) Mauricio P. Pinto et al.   GYNECOLOGIC ONCOLOGY

Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality

(2018) Radoslaw Szmyd et al.   ONCOGENE

Treatment of soft tissue sarcoma: a focus on earlier stages

(2017) Alessandro Gronchi et al.   Future Oncology

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer

(2017) Pasi A. Jänne et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ras–MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells

(2017) Ho-June Lee et al.   MOLECULAR CANCER THERAPEUTICS

Intraoperative radiation therapy (IORT) in soft-tissue sarcoma

(2017) Falk Roeder et al.   Radiation Oncology

Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature

(2017) Rong-quan He et al.   Oncotarget

CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival

(2017) Dong-dong Cheng et al.   Scientific Reports

Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss

(2016) Lorena Lazo de la Vega et al.   HUMAN PATHOLOGY

A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup

(2016) Akira Kawai et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study

(2016) Antoine Italiano et al.   LANCET ONCOLOGY

Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients

(2016) Kazuhiro Tanaka et al.   World Journal of Surgical Oncology

Advances in sarcoma diagnostics and treatment

(2016) Amanda R. Dancsok et al.   Oncotarget

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors

(2016) D. Williams Parsons et al.   JAMA Oncology

Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)

(2015) E. Bompas et al.   ANNALS OF ONCOLOGY

SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma

(2015) Scott M. Schuetze et al.   CANCER

Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)

(2015) S. Stacchiotti et al.   CLINICAL CANCER RESEARCH

Multigene panels in prostate cancer risk assessment: a systematic review

(2015) Julian Little et al.   GENETICS IN MEDICINE

RNA sequencing of sarcomas with simple karyotypes: identification and enrichment of fusion transcripts

(2015) Jakob Hofvander et al.   LABORATORY INVESTIGATION

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

(2015) Francois Le Loarer et al.   NATURE GENETICS

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap

(2015) Tauno Metsalu et al.   NUCLEIC ACIDS RESEARCH

Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells

(2015) QU YANG et al.   ONCOLOGY REPORTS

Multiple Regions of Kaposi’s Sarcoma-Associated Herpesvirus ORF59 RNA are Required for Its Expression Mediated by Viral ORF57 and Cellular RBM15

(2015) Maria Massimelli et al.   Viruses-Basel

Genomic landscape of liposarcoma

(2015) Deepika Kanojia et al.   Oncotarget

The Fibroblast Growth Factor signaling pathway

(2015) David M. Ornitz et al.   Wiley Interdisciplinary Reviews-Developmental Biology

Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1

(2014) Lei Duan et al.   CANCER BIOLOGY & THERAPY

First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: Pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials

(2014) R.J. Young et al.   EUROPEAN JOURNAL OF CANCER

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

(2014) Ian Judson et al.   LANCET ONCOLOGY

Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors

(2014) J. F. Shern et al.   Cancer Discovery

Targeting Mutant KRAS for Anticancer Therapeutics: A Review of Novel Small Molecule Modulators

(2013) Yuanxiang Wang et al.   JOURNAL OF MEDICINAL CHEMISTRY

FGF Receptors: Cancer Biology and Therapeutics

(2013) Masaru Katoh et al.   MEDICINAL RESEARCH REVIEWS

Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway

(2012) Annamaria Spina et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

(2012) Winette TA van der Graaf et al.   LANCET

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

(2012) Guangchuang Yu et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

(2011) S.-R. Woo et al.   CANCER RESEARCH

Ribosomal Protein S6 Interacts with the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus

(2011) W. Chen et al.   JOURNAL OF VIROLOGY

An 18-gene signature (ColoPrint®) for colon cancer prognosis

(2011) Iain B. Tan et al.   Nature Reviews Clinical Oncology

Trends in survival for patients with metastatic soft-tissue sarcoma

(2010) Antoine Italiano et al.   CANCER

Multigene Classifiers, Prognostic Factors, and Predictors of Breast Cancer Clinical Outcome

(2009) Jeffrey S. Ross   ADVANCES IN ANATOMIC PATHOLOGY

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

(2009) M. D. Robinson et al.   BIOINFORMATICS